Detail akcie biote Rg-A online

Business Summary: biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, biote Corp revenues decreased 1% to $145.8M. Net income increased from $1.5M to $25.1M. Revenues reflect Pellet Procedures segment decrease of 7% to $105.2M, Training segment decrease of 23% to $886K. Net income reflects Gain (loss) from change in fair value of increase from $18.8M (expense) to $11.8M (income), Amortization of Computer Software in SGA decrease of 18% to $900K (expense).